The 2011 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Glomerulonephritis (GN) aims to assist practitioners caring for adults and children with GN. Guideline development followed an explicit process of evidence review and appraisal. The guideline contains chapters on various glomerular diseases: steroid-sensitive nephrotic syndrome in children; steroid-resistant nephrotic syndrome in children; minimal-change disease; idiopathic focal segmental glomerulosclerosis; idiopathic membranous nephropathy; membranoproliferative glomerulonephritis; infection-related glomerulonephritis; IgA nephropathy; Henoch-Schönlein purpura nephritis; lupus nephritis; pauci-immune focal and segmental necrotizing glomerulonephritis; and anti–glomerular basement membrane antibody glomerulonephritis. Treatment approaches are addressed in each chapter and guideline recommendations are based on systematic reviews of relevant trials. Appraisal of the quality of the evidence and the strength of recommendations followed the GRADE approach. Limitations of the evidence are discussed and specific suggestions are provided for future research.
Canadian Society of Nephrology
Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis
– Management of Nephrotic Syndrome in Children
– Management of Glomerulonephritis in Adults
KDOQI
US Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis
KHA-CARI
Commentary on the KDIGO Clinical Practice Guideline for Glomerulonephritis
Japanese
German
KDIGO-Leitlinien zur Behandlung von Glomerulonephritiden
Russian (Full Text)
Практические клинические рекомендации KDIGO по лечению гломерулонефритов
Turkish (Full Text)
KDIGO GLOMERÜLONEFRİT KLİNİK UYGULAMA KILAVUZU
DISCLAIMER: USE OF THE CLINICAL PRACTICE GUIDELINES
This Clinical Practice Guideline is based upon the best information available at the time of publication. The recommendations are designed to provide information and assist decision-making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health care professional making use of this Guideline is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol.
